Cancer Trials Australia (CTA) was engaged by the VCCC to examine five priority areas for improvement and harmonisation of clinical trial processes and services. These were: ethics and governance processes for trial initiation, patient accrual, streamlining of costs for phase one studies, cost streamlining for first time in human studies capability and capacity, and provision of clinical research biostatistical and bio-informatics services. CTA appointed HMA to assist in examining the first three priority areas and to address issues through proposing new solutions.
In order to develop the new solutions, by means of pilot projects, HMA consulted with VCCC members on current practice and performance parameters to:
Key components of the project included:
This project commenced in October 2012 and was completed in June 2014.